“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs ever get regulatory approval? It’s simple: just choose a “primary indication” to test your drug with. Of course, that choice itself is rather difficult when you’re considering a geroprotector. Here’s how investors think about it…

Ever hear about an exciting discovery in the biomedical world, then later wonder why it seemingly dropped off the face of the Earth? In fact, it’s par for the course for potential therapeutics to fail before they ever get off the ground, guided unwittingly by their enthusiastic champions straight into a boneyard strewn with the…

TIL that one of my favorite condiments, Liquid Smoke, is basically just like eating advanced glycation end products (AGEs). That and other gems can be found in Buck Institute researcher Pankaj Kapahi’s seminar on metabolism and aging, here. here Our very own James Peyer talks about the trajectory of the anti-aging field at TEDxStuttgart. Also see Fight…

“At what age would you like to get Alzheimer’s?” This was the question posed by venture capitalist, former stem cell biologist and Geroscience co-founder James Peyer at TEDxStuttgart last week. Peyer became a devotee and champion of the anti-aging movement early in his life, and over his career he’s watched the field mature from a collection…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD